Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
Lisanne S. Rigter(Dutch Cancer Society), Monique E. van Leerdam(Leiden University Medical Center), Richard W.M. van der Maazen(Radboud University Nijmegen), Cécile P.M. Janus(Erasmus MC Cancer Institute), Katarzyna Jóźwiak(The Netherlands Cancer Institute), Annemieke Cats(Oncode Institute), Judith M. Roesink(University Medical Center Utrecht), Leon M.G. Moons(University Medical Center Utrecht), Manon C.W. Spaander(Erasmus University Rotterdam), John Raemaekers(Radboud University Nijmegen), Flora E. van Leeuwen(The Netherlands Cancer Institute), Eefke Petersen(University Medical Center Utrecht), Tanya M. Bisseling(Radboud University Nijmegen), Pieternella J. Lugtenburg(Erasmus MC Cancer Institute), Jan Paul de Boer, Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Eveline M. A. Bleiker(Cancer Clinic), Gerrit A. Meijer(The Netherlands Cancer Institute), Beatriz Carvalho(Centro Universitário das Faculdades Metropolitanas Unidas), Hein te Riele(The Netherlands Cancer Institute), Pétur Snæbjörnsson(University of Iceland), Berthe M.P. Aleman(The Netherlands Cancer Institute)
Cited by 10
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k